Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (317) GO Terms (11) Nucleotides (95) Proteins (63) Interactants (889) Wiki
XB--853971

Papers associated with cftr (and Disease Ontology)



???displayGene.coCitedPapers???
Show all cftr papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

Estimating the true stability of the prehydrolytic outward-facing state in an ABC protein., Simon MA, Iordanov I, Szollosi A, Csanády L., Elife. October 2, 2023; 12                   

Clinical and molecular characterization of the R751L-CFTR mutation., Haq IJ, Althaus M, Gardner AI, Yeoh HY, Joshi U, Saint-Criq V, Verdon B, Townshend J, O'Brien C, Ben-Hamida M, Thomas M, Bourke S, van der Sluijs P, Braakman I, Ward C, Gray MA, Brodlie M., Am J Physiol Lung Cell Mol Physiol. February 1, 2021; 320 (2): L288-L300.

Simple binding of protein kinase A prior to phosphorylation allows CFTR anion channels to be opened by nucleotides., Mihályi C, Iordanov I, Töröcsik B, Csanády L., Proc Natl Acad Sci U S A. September 1, 2020; 117 (35): 21740-21746.

VX-770-mediated potentiation of numerous human CFTR disease mutants is influenced by phosphorylation level., Cui G, Stauffer BB, Imhoff BR, Rab A, Hong JS, Sorscher EJ, McCarty NA., Sci Rep. September 17, 2019; 9 (1): 13460.              

CFTR supports cell death through ROS-dependent activation of TMEM16F (anoctamin 6)., Simões F, Ousingsawat J, Wanitchakool P, Fonseca A, Cabrita I, Benedetto R, Schreiber R, Kunzelmann K., Pflugers Arch. February 1, 2018; 470 (2): 305-314.

Asymmetry of movements in CFTR's two ATP sites during pore opening serves their distinct functions., Sorum B, Töröcsik B, Csanády L., Elife. September 25, 2017; 6                         

Bacterial Sphingomyelinase is a State-Dependent Inhibitor of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)., Stauffer BB, Cui G, Cottrill KA, Infield DT, McCarty NA., Sci Rep. June 7, 2017; 7 (1): 2931.                

Functional and molecular identification of a TASK-1 potassium channel regulating chloride secretion through CFTR channels in the shark rectal gland: implications for cystic fibrosis., Telles CJ, Decker SE, Motley WW, Peters AW, Mehr AP, Frizzell RA, Forrest JN., Am J Physiol Cell Physiol. December 1, 2016; 311 (6): C884-C894.

Potentiators exert distinct effects on human, murine, and Xenopus CFTR., Cui G, Khazanov N, Stauffer BB, Infield DT, Imhoff BR, Senderowitz H, McCarty NA., Am J Physiol Lung Cell Mol Physiol. August 1, 2016; 311 (2): L192-207.

Structure-activity analysis of a CFTR channel potentiator: Distinct molecular parts underlie dual gating effects., Csanády L, Töröcsik B., J Gen Physiol. October 1, 2014; 144 (4): 321-36.                    

Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ΔF508 CFTR from thermal instability., Liu X, Dawson DC., Biochemistry. September 9, 2014; 53 (35): 5613-8.        

Three charged amino acids in extracellular loop 1 are involved in maintaining the outer pore architecture of CFTR., Cui G, Rahman KS, Infield DT, Kuang C, Prince CZ, McCarty NA., J Gen Physiol. August 1, 2014; 144 (2): 159-79.                          

Characterization of SLC26A9 in patients with CF-like lung disease., Bakouh N, Bienvenu T, Thomas A, Ehrenfeld J, Liote H, Roussel D, Duquesnoy P, Farman N, Viel M, Cherif-Zahar B, Amselem S, Taam RA, Edelman A, Planelles G, Sermet-Gaudelus I., Hum Mutat. October 1, 2013; 34 (10): 1404-14.

Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules., Woodward OM, Tukaye DN, Cui J, Greenwell P, Constantoulakis LM, Parker BS, Rao A, Köttgen M, Maloney PC, Guggino WB., Proc Natl Acad Sci U S A. March 26, 2013; 110 (13): 5223-8.

Sildenafil acts as potentiator and corrector of CFTR but might be not suitable for the treatment of CF lung disease., Leier G, Bangel-Ruland N, Sobczak K, Knieper Y, Weber WM., Cell Physiol Biochem. January 1, 2012; 29 (5-6): 775-90.

F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis., Martins JR, Kongsuphol P, Sammels E, Dahimène S, Aldehni F, Clarke LA, Schreiber R, de Smedt H, Amaral MD, Kunzelmann K., Biochim Biophys Acta. November 1, 2011; 1812 (11): 1385-92.

Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain., Chang MH, Plata C, Sindic A, Ranatunga WK, Chen AP, Zandi-Nejad K, Chan KW, Thompson J, Mount DB, Romero MF., J Biol Chem. October 9, 2009; 284 (41): 28306-18.

Regulatory interaction between CFTR and the SLC26 transporters., Shcheynikov N, Ko SB, Zeng W, Choi JY, Dorwart MR, Thomas PJ, Muallem S., Novartis Found Symp. January 1, 2006; 273 177-86; discussion 186-92, 261-4.

Cystic fibrosis transmembrane conductance regulator differentially regulates human and mouse epithelial sodium channels in Xenopus oocytes., Yan W, Samaha FF, Ramkumar M, Kleyman TR, Rubenstein RC., J Biol Chem. May 28, 2004; 279 (22): 23183-92.

Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes., Chernova MN, Jiang L, Shmukler BE, Schweinfest CW, Blanco P, Freedman SD, Stewart AK, Alper SL., J Physiol. May 15, 2003; 549 (Pt 1): 3-19.

???pagination.result.page??? 1